ask="4.08"
ask_size="100"
average_daily_volume="3141390"
bid="4.03"
bid_size="1000"
book_value="-1.75"
change="+0.00"
change_from_200_day_moving_average="-1.32"
change_from_50_day_moving_average="-1.37"
change_from_52_week_high="-4.94"
change_From_52_week_low="0.05"
change_in_percent="+0.00%"
close="4.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.24"
ex_dividend_date="N/A"
float_shares="122562000"
high="4.22"
high_52_weeks="9.02"
last_trade_date="12/30/2016"
last_trade_price="4.08"
last_trade_size="101184"
last_trade_time="4:00pm"
low="4.03"
low_52_weeks="4.03"
market_capitalization="528.83M"
moving_average_200_day="5.40"
moving_average_50_day="5.45"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.67"
open="4.10"
pe_ratio="N/A"
peg_ratio="-0.63"
percent_change_from_200_day_moving_average="-24.51%"
percent_change_from_50_day_moving_average="-25.12%"
percent_change_from_52_week_high="-54.74%"
percent_change_from_52_week_low="+1.24%"
previous_close="4.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="5.06"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="17.94"
stock_exchange="NGM"
symbol="MACK"
volume="1983050"
weeks_range_52="4.03 - 9.02"
